Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Court Denies Viaguara Trademark

By Pharmaceutical Processing | January 25, 2012

BRUSSELS (AP) — A European Union high court ruled on Wednesday that the name Viaguara cannot be registered as an EU trademark for energy and alcoholic drinks because it is too similar to the impotence pill Viagra.

The EU’s General Court ruled that the similarity allowed Viaguara “to take unfair advantage of the distinctive character or repute of the trademark Viagra.”

The Polish company by the same name had already applied for the EU trademark in 2005 but was refused. The court has now rejected the appeal. The General Court ruling itself can only be appealed on points of law.

The U.S. medical company Pfizer Inc. produces the erectile dysfunction pill Viagra.

Also because of the medical implications, the court said it was dangerous to let a mental link exist.

“Even if the non-alcoholic drinks concerned do not actually have the same benefits as a drug to treat erectile dysfunction, the consumer will be inclined to buy them thinking that he will find similar qualities, such as an increase in libido,” the court said in a statement.

Pfizer welcomed the ruling. If Viaguara had been allowed to co-exist “the public would likely establish a ‘link’ between the two marks and Viaguara would take unfair advantage of the distinctive character or the repute of Pfizer’s well-known trademark,” the company said in a statement.

Pfizer said that since its introduction in 1998, Viagra has been prescribed to more than 37 million men worldwide.

Related Articles Read More >

FDA logo
Ultra Supplement announces recall for undeclared tadalafil
analyzing medical sample
Expert answers to nitrosamine impurity questions
Cardinal Health
Cardinal Health announces $124M settlement of investors’ opioid suit
FDA logo
FDA warns four companies over selling honey tainted with prescription drugs

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards